We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2019 23:05 | Agreed good post. 23p open likely Monday and huge upside now we are funded through to commercialisation. Literally breathtaking upside here | kirk 6 | |
06/12/2019 22:10 | I also spoke to Summit today & got a very positive feedback.I understand that our UK shares remain valid but just will not be traded on AIM & one can convert when ever time suits say 2021. I will be converting & then Buying more - at the close NASDAQ $1.54 = £0.23P not a bad close on the first day of the RNS. We are in a far better position now than yesterday.Onwards & upwards. PS I believe that Summit will support all long term private investors for which there are many of us here. | chrisatrdg | |
06/12/2019 21:24 | Very nice close on Nasdaq up over 5% so a lot of catching up on Monday on the London exchange !!!!Transformational news today as funding is now confirmed One listing on the main Nasdaq market and we will be awayExpecting huge upside once cancellation of aim end of year | kirk 6 | |
06/12/2019 21:17 | indeed, im, 50/50 on whether to put some more in. it will no doubt be clearer in a few weeks. | fragma | |
06/12/2019 21:05 | Absolutely right to question everything - it's a complicated transaction and will take a while to get to grips with. | bermudashorts | |
06/12/2019 20:56 | Thanks berm, i obviously missed that. but it's always prudent to query all avenues. as always you are on the ball and well researched. | fragma | |
06/12/2019 20:51 | Sorry fragma, I'm not with you, can you explain what you're concerned about? By the way, Summit has applied to the Takeover Panel for a waiver re. Rule 9 and it has been granted subject to the passing of resolutions at the General Meeting. | bermudashorts | |
06/12/2019 20:49 | berniemadoff, It seems you have some homework to catch up on ??? let us know when you think you know what you are talking about. | fragma | |
06/12/2019 20:45 | "Requirement for a mandatory offer: Where a bidder is interested in shares carrying 30% or more of the target’s voting share rights, the bidder must make a mandatory offer in cash at no less than the highest price paid during the preceding 12 months (often referred to as a "Rule 9 offer"). Mandatory offers can only be conditional on the bidder receiving acceptances that, together with any shares already held or acquired during the offer, would give the bidder and its concert parties more than 50% of the voting rights. As such, bidders cannot rely on other conditions to protect themselves." hxxps://www.burges-s | fragma | |
06/12/2019 20:41 | Only an imbecile really thinks your shares will be taken off you | bernymadoff | |
06/12/2019 20:40 | thanks bermuda, however do you honestly think that that is the way it will stay in the long run ? | fragma | |
06/12/2019 20:36 | The Notice of General Meeting and Shareholder Circular is available for download from Summit's website. The circular clearly states that following delisting from AIM the ADSs will remain listed on NASDAQ and 'all public trading of securities in the Company will take place on Nasdaq by way of ADSs'. | bermudashorts | |
06/12/2019 20:34 | by law, anyone that ends up with 30% or more of the company will be required to make a mandatory offer to all shareholders to aquire 100% of all shares in issue. it will be voted on in an EGM and shareholders can refuse if they want, but if you dont get a majority, your shares will be taken off you with whether you like it or not. Either way, it will be a very entertaining few weeks to come. | fragma | |
06/12/2019 20:29 | Agreed this should not have dropped 10%. Done the opposite on the Nasdaq so we should be up 15% Monday on aim | kirk 6 | |
06/12/2019 20:25 | lol, i will chuck in my whole pension, because no one ever lost any money on bernie maddof's advice :) | fragma | |
06/12/2019 20:22 | AIM is a casino rigged by MMs and brokers. Nasdaq is a much more level playing field. Watch how this rerates now over the coming sessions | bernymadoff | |
06/12/2019 20:21 | someuwin, respectfully i have to disagree. I am not saying that you are Wrong, However there is another more common and usual route that these sort of transactions take. The ADR's will more than likely get cancelled along with the AIM shares, and the company will be taken private with the shareholders given the option of redeeming their shares for 90 cents in the dollar. | fragma | |
06/12/2019 20:19 | Up over 5% now big gap up on Monday on aim | kirk 6 | |
06/12/2019 20:15 | Haha take it you are joking thenWhat's not good in a much more liquid stock, fully funded and the price rising quite Substantially over on the Nasdaq now the positive reality sets in. | kirk 6 | |
06/12/2019 20:15 | The US ADRs (American Depositary Receipt) can't exist on their own, they're just a proxy for the UK AIM shares. If they cancel the AIM listing but want to keep the US listing they'll have to convert the existing shares to full status US shares. Thus all our shares will automatically convert over (and can be held in ISA's and SIPPs as normal - I have loads of APPL, GOOGL, FB etc in these accounts). This in itself should significantly boost the share price. I've noticed with other stocks that although normally Nasdaq rates tech / pharma stocks on much higher ratings, if a stock is dual listed with AIM then the AIM market will act as a drag constantly pulling the valuation down. All in all, today's news looks transformational to me. | someuwin | |
06/12/2019 20:14 | I spoke to the company earlier today and they said they will be releasing more info about how PIs can convert their stock into Nasdaq shares. Apparently there is already a vehicle for doing so although I didnt get into the specifics. They're very excited by the investment and the move to Nasdaq. I have never in my life come across a listed company where the major shareholder whi has already invested $25m then pumps in the best part of another $50m to take it forward. Yes some will say he's a multi billionaire but even people like that don't throw $75m at something that's risky. Remember this is the same guy who sold Pharmacyclics in 2015 for $21bn in one of the biggest pharma deals ever. I suspect he has similar ambitions here. | bernymadoff | |
06/12/2019 20:10 | hmm, thanks, as I thought. doesn't look good, does it ? | fragma | |
06/12/2019 20:06 | I trade many stocks on the Nasdaq but you can see and compare on ADVFN SMMT considering the value of each trade as well the Nasdaq is the main market for SUmmit | kirk 6 | |
06/12/2019 20:01 | Kirk, since you seem to be looking at it at the moment, could you kindly give us some comparisons of the volume on the aim vs the adr markets over say the last month and if you have time, the last year ? Last time I checked, the ADR market volumes were miniscule and paled in comaprison to the AIM trades and made me wonder if it was worth the money to keep the listing over there ? | fragma |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions